What can i take instead of statins to lower cholesterol
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Alternatives to Statins for Lowering Cholesterol
Introduction to Cholesterol Management
Managing low-density lipoprotein cholesterol (LDL-C) is crucial for reducing the risk of cardiovascular diseases. While statins are the gold standard for lowering LDL-C, some patients either do not achieve their cholesterol goals or cannot tolerate statins due to adverse effects. Fortunately, several non-statin alternatives have shown efficacy in lowering LDL-C levels.
Ezetimibe: Cholesterol Absorption Inhibitor
Ezetimibe works by inhibiting the absorption of cholesterol in the intestines. When used alone, it can reduce LDL-C by about 18% and by an additional 25% when combined with statin therapy. This makes it a viable option for patients who need further LDL-C reduction beyond what statins can provide.
PCSK9 Inhibitors: Evolocumab and Alirocumab
PCSK9 inhibitors, such as evolocumab and alirocumab, are monoclonal antibodies that significantly lower LDL-C levels by preventing the degradation of LDL receptors in the liver. Evolocumab can reduce LDL-C by 53% to 56% from baseline. Both evolocumab and alirocumab have been shown to be highly effective when added to maximally tolerated statins, making them suitable for patients who require substantial LDL-C reduction .
Bempedoic Acid and Inclisiran: Emerging Therapies
Bempedoic acid and inclisiran are newer non-statin drugs that have shown promising results in clinical trials. Bempedoic acid, especially when combined with ezetimibe, has demonstrated significant LDL-C lowering effects. Inclisiran, a small interfering RNA, also effectively reduces LDL-C levels and has a favorable safety profile.
Nutraceuticals: Red Yeast Rice and Monacolin K
Nutraceuticals containing red yeast rice, which includes monacolin K, can be an alternative for patients with mild hypercholesterolemia. Studies have shown that low doses of monacolin K, combined with coenzyme Q10, grape seed, and olive leaf extracts, can reduce LDL-C by 16.77% to 26.46%. This makes it a potential option for those seeking a more natural approach to cholesterol management.
Dietary Interventions: Psyllium Fiber and Cholesterol-Lowering Foods
Dietary interventions can also play a significant role in lowering cholesterol. Psyllium fiber, when used as an adjunct to statins, has been shown to enhance the cholesterol-lowering efficacy of statins, equivalent to doubling the statin dose. Additionally, a dietary portfolio rich in plant sterols, soy protein, almonds, and viscous fibers has been found to reduce LDL-C levels comparably to first-generation statins.
Conclusion
For patients who cannot tolerate statins or need additional LDL-C reduction, several non-statin alternatives are available. Ezetimibe, PCSK9 inhibitors, bempedoic acid, inclisiran, nutraceuticals like red yeast rice, and dietary interventions such as psyllium fiber and cholesterol-lowering foods offer effective options for managing cholesterol levels. These alternatives provide flexibility in treatment plans, ensuring that patients can achieve their cholesterol goals and reduce cardiovascular risk.
Sources and full results
Most relevant research papers on this topic